No Data
No Data
Arcturus Therapeutics, CSL's Updated Covid-19 Vaccine Approved in Japan
Express News | Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-Amplifying Mrna Covid-19 Vaccine for Protection Against Jn.1 Strain, to Be Distributed in Japan by Meiji Seika Pharma
UBS Says Buy CSL Shares for a Double-digit Return in 2025
CSL Competitor Moderna Shifts Flu Vaccine Strategy -- Market Talk
Helen Badger Se Une a Los Líderes De Critical IoT Connectivity, CSL Group, Como Directora De Marketing
Investing for Growth? Here Are 6 ASX Stocks Macquarie Tips to Outperform
No Data
No Data